Recall: D-1467-2019

Class II - Potentially Harmful

Class IIClassification

2019-05-09Initiated

TerminatedStatus

American Health PackagingFirm

Product

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

Reason

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Distribution

Nationwide USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.